title: Antiretroviral drug resistance in human immunodeficiency virus type 2.
authors.affiliation: McGill University AIDS Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
authors.forename: Michel L
authors.initials: ML
authors.lastname: Ntemgwa
authors.forename: Thomas
authors.initials: T
authors.lastname: d'Aquin Toni
authors.forename: Bluma G
authors.initials: BG
authors.lastname: Brenner
authors.forename: Ricardo J
authors.initials: RJ
authors.lastname: Camacho
authors.forename: Mark A
authors.initials: MA
authors.lastname: Wainberg
mesh_terms: D000998:Antiviral Agents / Q000494:pharmacology*; D024882:Drug Resistance, Viral / Q000235:genetics / Q000502:physiology*; D016333:HIV Protease / Q000737:chemistry / Q000235:genetics; D017320:HIV Protease Inhibitors / Q000494:pharmacology; D015498:HIV-2 / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D012194:RNA-Directed DNA Polymerase / Q000737:chemistry / Q000235:genetics
chemical_list: D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D012194:RNA-Directed DNA Polymerase; D016333:HIV Protease